Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.

Shiga toxin-producing Escherichia coli (STEC) cause infections in humans ranging from asymptomatic carriage to bloody diarrhoea and haemolytic uremic syndrome (HUS). Here we present whole genome comparison of Norwegian non-O157 STEC strains with the aim to distinguish between strains with the potent...

Full description

Bibliographic Details
Main Authors: Kjersti Haugum, Jostein Johansen, Christina Gabrielsen, Lin T Brandal, Kåre Bergh, David W Ussery, Finn Drabløs, Jan Egil Afset
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4216125?pdf=render
id doaj-53f0db36d86e48f7a594428b8aa7ab46
record_format Article
spelling doaj-53f0db36d86e48f7a594428b8aa7ab462020-11-24T21:52:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e11178810.1371/journal.pone.0111788Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.Kjersti HaugumJostein JohansenChristina GabrielsenLin T BrandalKåre BerghDavid W UsseryFinn DrabløsJan Egil AfsetShiga toxin-producing Escherichia coli (STEC) cause infections in humans ranging from asymptomatic carriage to bloody diarrhoea and haemolytic uremic syndrome (HUS). Here we present whole genome comparison of Norwegian non-O157 STEC strains with the aim to distinguish between strains with the potential to cause HUS and less virulent strains. Whole genome sequencing and comparisons were performed across 95 non-O157 STEC strains. Twenty-three of these were classified as HUS-associated, including strains from patients with HUS (n = 19) and persons with an epidemiological link to a HUS-case (n = 4). Genomic comparison revealed considerable heterogeneity in gene content across the 95 STEC strains. A clear difference in gene profile was observed between strains with and without the Locus of Enterocyte Effacement (LEE) pathogenicity island. Phylogenetic analysis of the core genome showed high degree of diversity among the STEC strains, but all HUS-associated STEC strains were distributed in two distinct clusters within phylogroup B1. However, non-HUS strains were also found in these clusters. A number of accessory genes were found to be significantly overrepresented among HUS-associated STEC, but none of them were unique to this group of strains, suggesting that different sets of genes may contribute to the pathogenic potential in different phylogenetic STEC lineages. In this study we were not able to clearly distinguish between HUS-associated and non-HUS non-O157 STEC by extensive genome comparisons. Our results indicate that STECs from different phylogenetic backgrounds have independently acquired virulence genes that determine pathogenic potential, and that the content of such genes is overlapping between HUS-associated and non-HUS strains.http://europepmc.org/articles/PMC4216125?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kjersti Haugum
Jostein Johansen
Christina Gabrielsen
Lin T Brandal
Kåre Bergh
David W Ussery
Finn Drabløs
Jan Egil Afset
spellingShingle Kjersti Haugum
Jostein Johansen
Christina Gabrielsen
Lin T Brandal
Kåre Bergh
David W Ussery
Finn Drabløs
Jan Egil Afset
Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
PLoS ONE
author_facet Kjersti Haugum
Jostein Johansen
Christina Gabrielsen
Lin T Brandal
Kåre Bergh
David W Ussery
Finn Drabløs
Jan Egil Afset
author_sort Kjersti Haugum
title Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
title_short Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
title_full Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
title_fullStr Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
title_full_unstemmed Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
title_sort comparative genomics to delineate pathogenic potential in non-o157 shiga toxin-producing escherichia coli (stec) from patients with and without haemolytic uremic syndrome (hus) in norway.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Shiga toxin-producing Escherichia coli (STEC) cause infections in humans ranging from asymptomatic carriage to bloody diarrhoea and haemolytic uremic syndrome (HUS). Here we present whole genome comparison of Norwegian non-O157 STEC strains with the aim to distinguish between strains with the potential to cause HUS and less virulent strains. Whole genome sequencing and comparisons were performed across 95 non-O157 STEC strains. Twenty-three of these were classified as HUS-associated, including strains from patients with HUS (n = 19) and persons with an epidemiological link to a HUS-case (n = 4). Genomic comparison revealed considerable heterogeneity in gene content across the 95 STEC strains. A clear difference in gene profile was observed between strains with and without the Locus of Enterocyte Effacement (LEE) pathogenicity island. Phylogenetic analysis of the core genome showed high degree of diversity among the STEC strains, but all HUS-associated STEC strains were distributed in two distinct clusters within phylogroup B1. However, non-HUS strains were also found in these clusters. A number of accessory genes were found to be significantly overrepresented among HUS-associated STEC, but none of them were unique to this group of strains, suggesting that different sets of genes may contribute to the pathogenic potential in different phylogenetic STEC lineages. In this study we were not able to clearly distinguish between HUS-associated and non-HUS non-O157 STEC by extensive genome comparisons. Our results indicate that STECs from different phylogenetic backgrounds have independently acquired virulence genes that determine pathogenic potential, and that the content of such genes is overlapping between HUS-associated and non-HUS strains.
url http://europepmc.org/articles/PMC4216125?pdf=render
work_keys_str_mv AT kjerstihaugum comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT josteinjohansen comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT christinagabrielsen comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT lintbrandal comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT karebergh comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT davidwussery comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT finndrabløs comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
AT janegilafset comparativegenomicstodelineatepathogenicpotentialinnono157shigatoxinproducingescherichiacolistecfrompatientswithandwithouthaemolyticuremicsyndromehusinnorway
_version_ 1725875904156008448